©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessDiabetes mellitus, genetic; differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for familial Diabetes mellitus comprising 10 guideline-curated core genes and altogether 52 curated genes according to the clinical signs

ID
DP7546
Number of genes
51 Accredited laboratory test
Examined sequence length
24,9 kb (Core-/Core-canditate-Genes)
89,0 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ABCC84746NM_000352.6AD, AR
EIF2AK33351NM_004836.7AR
FOXP31296NM_014009.4XLR
GATA61788NM_005257.6AD
GCK1398NM_000162.5AD, AR
HNF1A1896NM_000545.8AD
HNF1B1674NM_000458.4AD
HNF4A1359NM_175914.4AD
INS333NM_000207.3AD, AR
KCNJ111173NM_000525.4AD
MNX11206NM_005515.4AD
NEUROD11071NM_002500.5AD, AR
PDX1852NM_000209.4AR
WFS12673NM_006005.3AD, AR
AGPAT2837NM_006412.4AR
AKT21446NM_001626.6AD
BLK1518NM_001715.3AD
BSCL21197NM_032667.6AR
CISD2408NM_001008388.5AR
DCAF171563NM_025000.4AR
DNAJC31515NM_006260.5AR
DYRK1B1890NM_004714.3AD
EIF2B1918NM_001414.4AD
GATA41329NM_002052.5AD
GLIS32328NM_152629.4AR
IER3IP1249NM_016097.5AR
INSR4149NM_000208.4AD
KLF111539NM_003597.5AD
LMNA1995NM_170707.4AD
LRBA8556NM_001199282.2AR
NEUROG3645NM_020999.4AR
NKX2-2822NM_002509.4AR
PAX41056NM_001366110.1AD
PAX61269NM_000280.5AD
PCBD1315NM_000281.4AR
PIK3R12175NM_181523.3AD
PLIN11569NM_002666.5AD
POLD13324NM_002691.4AD
PPARG1518NM_015869.5AD
PPP1R15B2142NM_032833.5AR
PTF1A987NM_178161.3AR
RFX62787NM_173560.4AR
SLC19A21494NM_006996.3AR
SLC29A31428NM_018344.6AR
SLC2A21575NM_000340.2AR
STAT32313NM_139276.3AD
TRMT10A1020NM_001134665.3AR
XRCC41005NM_003401.5AR
ZBTB202226NM_001164342.2AD
ZFP571611NM_001109809.5AD, AR
ZMPSTE241428NM_005857.5AR

Informations about the disease

Clinical Comment

While a minority of diabetic patients are affected by either autoimmune (type 1 diabetes or latent autoimmune diabetes in adults), monogenic or secondary (endocrine) forms, >80% of diabetics suffer from type 2 (T2D). T2D likely represents a spectrum ranging from purely monogenic disease to forms in which deleterious effects of environmental factors predominate over genetic susceptibility. While permanent neonatal diabetes is at one end of the spectrum, T2D in the elderly may represent the opposite extreme. In 20% of cases of ND, the genetic cause remains unknown. Monogenic non-autoimmune diabetes also encompasses a wide spectrum of phenotypes, namely neonatal diabetes, diabetes-associated syndromal disease, mitochondrial diabetes and inherited familial forms of early-onset diabetes, Maturity-Onset Diabetes of the Young (MODY). Although mutations in at least 14 different genes are associated with MODY, the causative gene remains still unknown in 10% of these patients. The proportion of monogenic diabetes in patients diagnosed before the age of 45 is likely to be 3-5%.

References: : https://www.ncbi.nlm.nih.gov/books/NBK1447/

https://www.ncbi.nlm.nih.gov/books/NBK500456/https://www.ncbi.nlm.nih.gov/books/NBK476444/https://www.ncbi.nlm.nih.gov/books/NBK4144/

 

Synonyms
  • Alias: Familial diabetes
  • Alias: Rare genetic diabetes mellitus
  • Allelic: Agammaglobulinemia 7, AR (PIK3R1)
  • Allelic: Aniridia (PAX6)
  • Allelic: Anterior segment dysgenesis 5, multiple subtypes (PAX6)
  • Allelic: Atrial septal defect 2 (GATA4)
  • Allelic: Atrial septal defect 9 (GATA6)
  • Allelic: Atrioventricular septal defect 4 (GATA4)
  • Allelic: Atrioventricular septal defect 5 (GATA)6
  • Allelic: Cardiomyopathy, dilated, 1A (LMNA)
  • Allelic: Carotid intimal medial thickness 1 (PPARG)
  • Allelic: Cataract 41 (WFS1)
  • Allelic: Cataract with late-onset corneal dystrophy (PAX6)
  • Allelic: Charcot-Marie-Tooth disease, type 2B1 (LMNA)
  • Allelic: Coloboma of optic nerve (PAX6
  • Allelic: Coloboma, ocular (PAX6)
  • Allelic: Colorectal cancer, susceptibility to, 10 (POLD1)
  • Allelic: Deafness, AD 6/14/38 (WFS1)
  • Allelic: Emery-Dreifuss muscular dystrophy 2, AD (LMNA)
  • Allelic: Emery-Dreifuss muscular dystrophy 3, AR (LMNA)
  • Allelic: Fanconi-Bickel syndrome (SLC2A2)
  • Allelic: Foveal hypoplasia 1 (PAX6)
  • Allelic: Heart-hand syndrome, Slovenian type (LMNA)
  • Allelic: Hepatic adenoma, somatic (HNF1A)
  • Allelic: Hyper-IgE recurrent infection syndrome (STAT3)
  • Allelic: Hyperinsulinemic hypoglycemia, familial, 2 (KCNJ11)
  • Allelic: Hyperinsulinemic hypoglycemia, familial, 5 (INSR)
  • Allelic: Hyperproinsulinemia (INS)
  • Allelic: Hypoinsulinemic hypoglycemia with hemihypertrophy (AKT2)
  • Allelic: Immunodeficiency 36 PIK3R1)
  • Allelic: Keratitis (PAX6)
  • Allelic: Leprechaunism (INSR)
  • Allelic: Malouf syndrome (LMNA)
  • Allelic: Mandibuloacral dysplasia (LMNA)
  • Allelic: Morning glory disc anomaly (PAX6)
  • Allelic: Muscular dystrophy, congenital (LMNA)
  • Allelic: Neuropathy, distal hereditary motor, type VC (BSCL2)
  • Allelic: Obesity, resistance to (PPARG)
  • Allelic: Obesity, severe (PPARG)
  • Allelic: Optic nerve hypoplasia (PAX6)
  • Allelic: Persistent truncus arteriosus (GATA6)
  • Allelic: Renal cell carcinoma (HNF1A. HNF1B)
  • Allelic: Restrictive dermopathy, lethal (LMNA)
  • Allelic: Restrictive dermopathy, lethal (ZMPSTE24)
  • Allelic: Silver spastic paraplegia syndrome (BSCL2)
  • Allelic: Testicular anomalies with/-out congenital heart disease (GATA4)
  • Allelic: Tetralogy of Fallot (GATA4)
  • Allelic: Tetralogy of Fallot (GATA6)
  • Allelic: Ventricular septal defect 1 (GATA4)
  • Allelic: Vissers-Bodmer syndrome (CNOT1)
  • Abdominal obesity-metabolic syndrome 3 (DYRK1B)
  • Asphyxiating thoracic dystrophy syndrome + infantile‐onset diabetes [panelapp] (PDIA6)
  • Ataxia, combined cerebellar + peripheral, with hearing loss + diabetes mellitus (DNAJC3)
  • Autoimmune disease, multisystem, infantile-onset, 1 (STAT3)
  • Currarino syndrome (MNX1)
  • Diabetes [panelapp] (PAX6)
  • Diabetes mellitus, insulin-dependent (HNF1A)
  • Diabetes mellitus, insulin-dependent, 2 (INS)
  • Diabetes mellitus, insulin-dependent, 20 (HNF1A)
  • Diabetes mellitus, insulin-resistant, with acanthosis nigricans (INSR)
  • Diabetes mellitus, ketosis-prone, susceptibility to (NKX2-2)
  • Diabetes mellitus, ketosis-prone, susceptibility to (PAX4)
  • Diabetes mellitus, neonatal, with congenital hypothyroidism (GLIS3)
  • Diabetes mellitus, noninsulin-dependent (ABCC8)
  • Diabetes mellitus, noninsulin-dependent (HNF4A)
  • Diabetes mellitus, noninsulin-dependent (SLC2A2)
  • Diabetes mellitus, noninsulin-dependent, 2 (HNF1A)
  • Diabetes mellitus, noninsulin-dependent, association with (WFS1)
  • Diabetes mellitus, noninsulin-dependent, late onset (GCK)
  • Diabetes mellitus, permanent neonatal 1 (GCK)
  • Diabetes mellitus, permanent neonatal 3, with/-out neurologic features (ABCC8)
  • Diabetes mellitus, permanent neonatal 4 (INS)
  • Diabetes mellitus, transient neonatal 1 (ZPF57)
  • Diabetes mellitus, transient neonatal 2 (ABCC8)
  • Diabetes mellitus, transient neonatal 3 (KCNJ11)
  • Diabetes mellitus, type 2 (AKT2, NKX2-2, PAX4)
  • Diabetes mellitus, type II, susceptibility to (KCNJ11, PDX1)
  • Diabetes, mellitus, insulin-dependent, susceptibility to, 10 (IL2RA)
  • Diabetes, permanent neonatal 2, with/-out neurologic features (KCNJ11)
  • Diabetes, type 2 (PPARG)
  • Diarrhea 4, malabsorptive, congenital (NEUROG3)
  • Encephalopathy, progressive, with or without lipodystrophy (BSCL2)
  • Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young (HNF4A)
  • Histiocytosis-lymphadenopathy plus syndrome (SLC29A3)
  • Holoprosencephaly 12, with or without pancreatic agenesis (CNOT1)
  • Hutchinson-Gilford progeria (LMNA)
  • Hyperinsulinemic hypoglycemia, familial, 1 (ABCC8)
  • Hyperinsulinemic hypoglycemia, familial, 3 (GCK)
  • Hyperphenylalaninemia, BH4-deficient, D (PCBD1)
  • Hypoglycemia of infancy, leucine-sensitive (ABCC8)
  • Immunodeficiency 41 with lymphoproliferation + autoimmunity (IL2RA)
  • Immunodeficiency, common variable, 8, with autoimmunity (LRBA)
  • Immunodysregulation, polyendocrinopathy + enteropathy, XL (FOXP3)
  • Insulin resistance, severe, digenic (PPARG)
  • Leukoencephalopathy with vanishing white matter 1, +/- ovarian failure (EIF2B1)
  • Lipodystrophy, congenital generalized, type 1 (AGPAT2)
  • Lipodystrophy, congenital generalized, type 2 (BSCL2)
  • Lipodystrophy, familial partial, type 2 (LMNA)
  • Lipodystrophy, familial partial, type 3 (PPARG)
  • Lipodystrophy, familial partial, type 4 (PLIN1)
  • MEHMO [Mental retard., Epilepsy, Hypogonadism/-genitalism, Microcephaly, Obesity] syndrome (EIF2S3)
  • MODY, type I (HNF4A)
  • MODY, type II (GCK)
  • MODY, type III (HNF1A)
  • MODY, type IV (PDX1)
  • MODY, type IX (NKX2-2)
  • MODY, type IX (PAX4)
  • MODY, type VI (NEUROD1)
  • MODY, type VII (KLF11)
  • MODY, type VIII (CEL)
  • MODY, type X (INS)
  • MODY, type XI (BLK)
  • MODY, type XIII (KCNJ11)
  • MODY, type XIV (APPL1)
  • Mandibular hypoplasia, deafness, progeroid features + lipodystrophy syndrome (POLD1)
  • Mandibuloacral dysplasia with type B lipodystrophy (ZMPSTE24)
  • Microcephaly, epilepsy + diabetes syndrome (IER3IP1)
  • Microcephaly, epilepsy + diabetes syndrome 2 (YIPF5)
  • Microcephaly, short stature + impaired glucose metabolism 1 (TRMT10A)
  • Microcephaly, short stature + impaired glucose metabolism 2 (PPP1R15B)
  • Mitchell-Riley syndrome (RFX6)
  • Neonatal diabetes mellitus [MONDO:0016391, panelapp] (ONECUT1)
  • Neonatal diabetes mellitus [MONDO:0016391, panelapp] (ZNF808)
  • Neonatal diabetes mellitus [MONDO:0016391] (IL2RA)
  • ONECUT1-associated neonatal diabetes [panelapp] (ONECUT1)
  • Pancreatic + cerebellar agenesis (PTF1A)
  • Pancreatic agenesis + congenital heart defects (GATA6)
  • Pancreatic agenesis 1 (PDX1)
  • Pancreatic agenesis 2 (PTF1A)
  • Pancreatic agenesis [MONDO:0009832, panelapp] (ZNF808)
  • Primrose syndrome (ZBTB20)
  • Rabson-Mendenhall syndrome (INSR)
  • Renal cysts + diabetes syndrome (HNF1B)
  • SHORT syndrome (PIK3R1)
  • Short stature, microcephaly + endocrine dysfunction (XRCC4)
  • Thiamine-responsive megaloblastic anemia syndrome (SLC19A2)
  • Type 2 diabetes mellitus (HNF1B)
  • Type 2 diabetes mellitus, susceptibility to (NEUROD1)
  • Wolcott-Rallison syndrome (EIFAK3)
  • Wolfram syndrome 1 (WFS1)
  • Wolfram syndrome 2 (CISD2)
  • Wolfram-like syndrome, AD (WFS1)
  • Woodhouse-Sakati syndrome (DCAF17)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboratory requirement

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.